SCHEMBL6624662

SCHEMBL6624662

S[C@H]1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL132899 1.00
SCHEMBL4354716 1.00
Hydrochloric Acid SCHEMBL9855170 0.97
Hydrochloric Acid SCHEMBL9855179 0.97
Hydrochloric Acid SCHEMBL27472439 0.97
Methane SCHEMBL27305703 0.97
Hydrochloric Acid SCHEMBL6168410 0.97
Formamide SCHEMBL27280835 0.84
SCHEMBL3064287 0.81
SCHEMBL1068577 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1251133-B1 NOVEL CARBAPENEM DERIVATIVES MEIJI SEIKA KAISHA (JP) 2004-10-13 EP claimed
US-6680313-B2 1-HYDROXYETHYL-2(IMIDAZO(5,1B)THIAZOL-2-YL-1-CARBAPEN-2-EM-3-C CARBOXYLIC ACID OR SALT, EXCELLENT ANTIBIOTIC ACTIVITY AGAINST A WIDE SPECTRUM OF BACTERIA MEIJI SEIKA KAISHA, LTD. (JP) 2004-01-20 US claimed
US-20030027809-A1 Novel carbapenum derivatives MEIJI SEIKA KAISHA, LTD. (JP) 2003-02-06 US claimed
EP-1251133-A1 NOVEL CARBAPENEM DERIVATIVES MEIJI SEIKA KAISHA LTD. (JP) 2002-10-23 EP claimed
US-20250118803-A1 NONAQUEOUS ELECTROLYTE FOR NONAQUEOUS-ELECTROLYTE CELL, AND NONAQUEOUS-ELECTROLYTE CELL PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2025-04-10 US disclosed
EP-4475255-A1 NONAQUEOUS ELECTROLYTE FOR NONAQUEOUS-ELECTROLYTE CELL, AND NONAQUEOUS-ELECTROLYTE CELL Panasonic Intellectual Property Management Co., Ltd. (JP) 2024-12-11 EP disclosed
US-20220024920-A1 ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOF HORIZON ORPHAN LLC (US) 2022-01-27 US disclosed
US-10906904-B2 ADO-resistant cysteamine analogs and uses thereof HORIZON ORPHAN LLC (US) 2021-02-02 US disclosed
US-20210002254-A1 MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2021-01-07 US disclosed
EP-3316877-B1 ADO-RESISTANT CYSTEAMINE ANALOGS AND USES THEREOF HORIZON ORPHAN LLC (US) 2019-10-30 EP disclosed
US-10172858-B2 Combination pharmaceutical compositions and uses thereof INTELLIKINE LLC (US) 2019-01-08 US disclosed
US-9669032-B2 Enhanced treatment regimens using mTOR inhibitors INTELLIKINE LLC (US) 2017-06-06 US disclosed
US-20030027809-A1 Novel carbapenum derivatives MEIJI SEIKA KAISHA, LTD. (JP) 2003-02-06 US disclosed
US-20030022881-A1 Novel carbapenem derivatives of quarternary salt type MEIJI SEIKA KAISHA, LTD. (JP) 2003-01-30 US disclosed
EP-1251133-A1 NOVEL CARBAPENEM DERIVATIVES MEIJI SEIKA KAISHA LTD. (JP) 2002-10-23 EP disclosed
EP-1251134-A1 NOVEL CARBAPENEM DERIVATIVES OF QUATERNARY SALT TYPE MEIJI SEIKA KAISHA LTD. (JP) 2002-10-23 EP disclosed
EP-0521524-B1 Aminooxypyrrolidinylthiocarbapenem compounds SHIONOGI & CO (JP) 1997-04-09 EP disclosed
US-5523415-A BACTERICIDES SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) 1996-06-04 US disclosed
US-5360798-A BACTERICIDES SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) 1994-11-01 US disclosed
EP-0521524-A1 Aminooxypyrrolidinylthiocarbapenem compounds SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) 1993-01-07 EP disclosed